Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-25 5:16 pm Purchase | 2021-10-21 | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital, LP | 1,266,884 5.180% | 1,266,884 (New Position) | Filing History |
| 2021-10-25 5:12 pm Purchase | 2021-10-22 | 13G | Passage Bio, Inc. PASG | Deep Track Capital, LP | 142,647 5.270% | 142,647 (New Position) | Filing History |
| 2021-10-12 4:55 pm Purchase | 2021-10-08 | 13G | Assembly Biosciences, Inc. ASMB | Deep Track Capital, LP | 199,490 5.320% | 199,490 (New Position) | Filing History |
| 2021-09-24 5:01 pm Purchase | 2021-09-21 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital, LP | 1,819,689 9.900% | 1,819,689 (New Position) | Filing History |
| 2021-09-01 4:20 pm Purchase | 2021-08-31 | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital, LP | 3,856,463 7.530% | 3,856,463 (New Position) | Filing History |
| 2021-08-13 4:27 pm Purchase | 2021-08-04 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital, LP | 3,090,200 5.090% | 3,090,200 (New Position) | Filing History |
| 2021-08-05 5:10 pm Purchase | 2021-07-30 | 13G | AVROBIO, Inc. AVRO | Deep Track Capital, LP | 184,261 5.070% | 184,261 (New Position) | Filing History |
| 2021-05-14 4:05 pm Purchase | 2021-05-14 | 13G | Magenta Therapeutics, Inc. MGTA | Deep Track Capital, LP | 4,155,555 7.140% | 4,155,555 (New Position) | Filing History |
| 2021-04-22 5:56 pm Purchase | 2021-04-19 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Deep Track Capital, LP | 1,898,666 5.050% | 1,898,666 (New Position) | Filing History |